Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
15000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Substantial exercise of the 38th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
15,000,000 new shares (number of shares issued from 1 April to 16 April 2026)
Existing Shares and Increase
+3.91%Rate of increase
383,643,700 shares398,643,700Shares
15,000,000 shares issued from the beginning of the month ÷ 383,643,700 shares outstanding at the end of the prior month. Approximately 3.91%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. Exercise prices of ¥20.5, ¥22.4 and ¥21.4 are stated for the period, but details of the adjustment clause and the floor price are not disclosed
Number of Stock Acquisition Rights
Total issued: 796,000 rights (150,000 rights, equivalent to 18.84% of the total issued); unexercised at the end of the prior month: 396,000 rights; currently unexercised: 246,000 rights
Most recent equity financing
Issuance of new shares and the 38th Stock Acquisition Rights (with an exercise price adjustment clause) through a third-party allotment, announced on 21 November 2025
| Item | Details |
|---|---|
| Type of issuance or disposal | Substantial exercise of the 38th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 15,000,000 new shares (number of shares issued from 1 April to 16 April 2026) |
| Dilution Rate | 15,000,000 shares issued from the beginning of the month ÷ 383,643,700 shares outstanding at the end of the prior month. Approximately 3.91% |
| Total number of issued shares | 383,643,700 shares (as of the end of the month preceding the month under review) → 398,643,700 shares (shares outstanding at the end of the prior month plus shares issued from the beginning of the month)（Approximately 3.91%） |
| Exercise price | Subject to an exercise price adjustment clause. Exercise prices of ¥20.5, ¥22.4 and ¥21.4 are stated for the period, but details of the adjustment clause and the floor price are not disclosed |
| Number of Stock Acquisition Rights | Total issued: 796,000 rights (150,000 rights, equivalent to 18.84% of the total issued); unexercised at the end of the prior month: 396,000 rights; currently unexercised: 246,000 rights |
| Most recent equity financing | Issuance of new shares and the 38th Stock Acquisition Rights (with an exercise price adjustment clause) through a third-party allotment, announced on 21 November 2025 |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the status of the substantial exercise. No information is provided on the use of proceeds or the reasons for exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.